Inflastar-D Tablet is a combination medication containing Diclofenac 50 mg and Serratiopeptidase 10 mg, formulated to provide effective relief from pain and inflammation. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for pain, inflammation, and fever. Serratiopeptidase, a proteolytic enzyme, enhances the anti-inflammatory action by breaking down inflammatory mediators and promoting the resolution of edema and tissue repair. This synergistic combination is particularly beneficial in managing conditions such as musculoskeletal disorders, postoperative inflammation, rheumatoid arthritis, osteoarthritis, and soft tissue injuries. Inflastar-D is indicated for short-term use to alleviate moderate to severe pain and inflammation, improving patient mobility and quality of life. The tablet should be administered orally as prescribed by a healthcare professional, with caution advised in patients with gastrointestinal ulcers, bleeding disorders, or hypersensitivity to NSAIDs or enzymes. Regular monitoring is recommended during prolonged therapy to detect any adverse effects such as gastrointestinal discomfort, renal impairment, or allergic reactions. Inflastar-D offers a balanced approach to pain management by combining potent anti-inflammatory and proteolytic properties in a single dosage form.